Advisory Board on Radiation and Worker Health, National Institute for Occupational Safety and Health, 1379-1380 [2014-00042]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 5 / Wednesday, January 8, 2014 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Advisory Committee to the Director,
Centers for Disease Control and
Prevention—Health Disparities
Subcommittee
Advisory Board on Radiation and
Worker Health, National Institute for
Occupational Safety and Health
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned subcommittee:
mstockstill on DSK4VPTVN1PROD with NOTICES
Time and Date: 10:00 a.m.–12:00 p.m.
EDT, February 13, 2014.
Place: Teleconference.
Status: This meeting is open to the public,
limited only by the availability of telephone
ports. The public is welcome to participate
during the public comment period, which is
tentatively scheduled from 11:45 a.m. to
11:55 a.m. To participate on the
teleconference, please dial (866) 763–0273
and enter code 6158968.
Purpose: The Subcommittee will provide
advice to the CDC Director through the
Advisory Committee to the Director (ACD) on
strategic and other health disparities and
health equity issues and provide guidance on
opportunities for CDC.
Matters To Be Discussed: The Health
Disparities Subcommittee (HSD) members
will discuss some of the current health equity
activities at CDC, as well as discuss health
equity recommendations to the CDC ACD.
The agenda is subject to change as
priorities dictate.
Contact Person for More Information:
Leandris Liburd, Ph.D., M.P.H., M.A.,
Designated Federal Officer, Health
Disparities Subcommittee, ACD, CDC, 1600
Clifton Road NE., M/S K–77, Atlanta, Georgia
30333, Telephone (770) 488–8182, Email:
LEL1@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Gary J. Johnson,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2014–00043 Filed 1–7–14; 8:45 am]
BILLING CODE 4163–18–P
VerDate Mar<15>2010
16:42 Jan 07, 2014
Jkt 232001
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), and pursuant to the
requirements of 42 CFR 83.15(a), the
Centers for Disease Control and
Prevention (CDC), announces the
following meeting of the Advisory
Board on Radiation and Worker Health
(ABRWH or Advisory Board), National
Institute for Occupational Safety and
Health (NIOSH):
Time and Date: (All times are Central
Standard Time) 9 a.m.–5:30 p.m., January 28,
2014.
Public Comment Time and Date: (All times
are Central Standard Time) 5:30 p.m.–6:30
p.m., January 28, 2014.
*Please note that the public comment
period may end before the time indicated,
following the last call for comments.
Members of the public who wish to provide
public comments should plan to attend the
public comment session at the start time
listed.
Place: Crowne Plaza, 1301 Wyandotte,
Kansas City, MO, 64105 Phone: 816–460–
6664; Fax: 816–474–0424. Audio Conference
Call via FTS Conferencing. The USA toll-free,
dial-in number is 1–866–659–0537 with a
pass code of 9933701. Live Meeting
Connection: https://www.livemeeting.com/
cc/cdc/join?id=JKQMG2&role=
attend&pw=ABRWH; Meeting ID: JKQMG2;
Entry Code: ABRWH
Status: Open to the public, limited only by
the space available. The meeting space
accommodates approximately 150 people.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation Program
Act of 2000 to advise the President on a
variety of policy and technical functions
required to implement and effectively
manage the new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines which
have been promulgated by the Department of
Health and Human Services (HHS) as a final
rule, advice on methods of dose
reconstruction which have also been
promulgated by HHS as a final rule, advice
on the scientific validity and quality of dose
estimation and reconstruction efforts being
performed for purposes of the compensation
program, and advice on petitions to add
classes of workers to the Special Exposure
Cohort (SEC).
In December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS, which
subsequently delegated this authority to the
CDC. NIOSH implements this responsibility
for CDC. The charter was issued on August
PO 00000
Frm 00018
Fmt 4703
Sfmt 4703
1379
3, 2001, renewed at appropriate intervals,
and will expire on August 3, 2015.
Purpose: This Advisory Board is charged
with a) providing advice to the Secretary,
HHS, on the development of guidelines
under Executive Order 13179; b) providing
advice to the Secretary, HHS, on the
scientific validity and quality of dose
reconstruction efforts performed for this
program; and c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at any
Department of Energy facility who were
exposed to radiation but for whom it is not
feasible to estimate their radiation dose, and
on whether there is reasonable likelihood
that such radiation doses may have
endangered the health of members of this
class.
Matters To Be Discussed: The agenda for
the Advisory Board meeting includes: NIOSH
Program Update; Department of Labor
Program Update; Department of Energy
Program Update; SEC petitions for: Joslyn
Manufacturing and Supply Company (Fort
Wayne, IN) and Kansas City Plant (Kansas
City, MO); SEC Issues Work Group Report on
‘‘Sufficient Accuracy’’/Co-Worker Dose
Modeling; SEC Petitions Update, and Board
Work Sessions.
The agenda is subject to change as
priorities dictate.
In the event an individual cannot attend,
written comments may be submitted in
accordance with the redaction policy
provided below. Any written comments
received will be provided at the meeting and
should be submitted to the contact person
below well in advance of the meeting.
Policy on Redaction of Board Meeting
Transcripts (Public Comment): (1) If a person
making a comment gives his or her personal
information, no attempt will be made to
redact the name; however, NIOSH will redact
other personally identifiable information,
such as contact information, social security
numbers, case numbers, etc., of the
commenter.
(2) If an individual in making a statement
reveals personal information (e.g., medical or
employment information) about themselves
that information will not usually be redacted.
The NIOSH Freedom of Information Act
(FOIA) coordinator will, however, review
such revelations in accordance with the
Federal Advisory Committee Act and if
deemed appropriate, will redact such
information.
(3) If a commenter reveals personal
information concerning a living third party,
that information will be reviewed by the
NIOSH FOIA coordinator, and upon
determination, if deemed appropriate, such
information will be redacted, unless the
disclosure is made by the third party’s
authorized representative under the Energy
Employees Occupational Illness
Compensation Program Act (EEOICPA)
program.
(4) In general, information concerning a
deceased third party may be disclosed;
however, such information will be redacted
if (a) the disclosure is made by an individual
other than the survivor claimant, a parent,
spouse, or child, or the authorized
representative of the deceased third party; (b)
E:\FR\FM\08JAN1.SGM
08JAN1
1380
Federal Register / Vol. 79, No. 5 / Wednesday, January 8, 2014 / Notices
if it is unclear whether the third party is
living or deceased; or (c) the information is
unrelated or irrelevant to the purpose of the
disclosure.
The Board will take reasonable steps to
ensure that individuals making public
comment are aware of the fact that their
comments (including their name, if provided)
will appear in a transcript of the meeting
posted on a public Web site. Such reasonable
steps include: (a) A statement read at the start
of each public comment period stating that
transcripts will be posted and names of
speakers will not be redacted; (b) A printed
copy of the statement mentioned in (a) above
will be displayed on the table where
individuals sign up to make public
comments; (c) A statement such as outlined
in (a) above will also appear with the agenda
for a Board Meeting when it is posted on the
NIOSH Web site; (d) A statement such as in
(a) above will appear in the Federal Register
Notice that announces Board and
Subcommittee meetings.
Contact Person For More Information:
Theodore Katz, M.P.A., Designated Federal
Officer, NIOSH, CDC, 1600 Clifton Road NE.,
MS E–20, Atlanta, GA 30333, Telephone:
(513) 533–6800, Toll Free: 1–800–CDC–
INFO, Email: dcas@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register Notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Gary J. Johnson,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2014–00042 Filed 1–7–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
mstockstill on DSK4VPTVN1PROD with NOTICES
Request for Nominations of
Candidates To Serve on the CDC/
HRSA Advisory Committee on HIV,
Viral Hepatitis and STD Prevention and
Treatment, Centers for Disease Control
and Prevention, Health Resources and
Services Administration
The Centers for Disease Control and
Prevention (CDC) is soliciting
nominations for possible membership
on the CDC/HRSA Advisory Committee
on HIV, Viral Hepatitis and STD
Prevention and Treatment
(CHACHSPT).
The CHACHSPT provides advice to
the Secretary, HHS; the Director, CDC;
and the Administrator, Health
Resources and Services Administration
(HRSA), on objectives, strategies,
policies, and priorities for HIV, Viral
VerDate Mar<15>2010
16:42 Jan 07, 2014
Jkt 232001
Hepatitis, and STD prevention and
treatment efforts including surveillance
of HIV infection, AIDS, Viral Hepatitis,
other STDs, and related behaviors;
epidemiologic, behavioral, health
services, and laboratory research on
HIV/AIDS, Viral Hepatitis, and other
STDs; identification of policy issues
related to HIV/Viral Hepatitis/STD
professional education, patient
healthcare delivery, and prevention
services; agency policies about
prevention of HIV/AIDS, Viral Hepatitis
and other STDs, treatment, healthcare
delivery, and research and training;
strategic issues influencing the ability of
CDC and HRSA to fulfill their missions
of providing prevention and treatment
services; programmatic efforts to
prevent and treat HIV, Viral Hepatitis,
and other STDs; and support to the
agencies in their development of
responses to emerging health needs
related to HIV, Viral Hepatitis and other
STDs.
The CHACHSPT consists of 18
experts knowledgeable in the fields of
public health, epidemiology, laboratory
practices, immunology, infectious
diseases, drug abuse, behavioral science,
health education, healthcare delivery,
state health programs, clinical care,
preventive health, medical education,
health services and clinical research,
and healthcare financing, who are
selected by the Secretary of the U.S.
Department of Health and Human
Services (HHS).
Nominations are being sought for
individuals who have expertise and
qualifications necessary to contribute to
the accomplishments of the Committee’s
objectives.
Nominees will be selected from
experts having experience in HIV/AIDS,
Viral Hepatitis and STD prevention,
control and treatment. Experts in the
disciplines of epidemiology, laboratory
practice, immunology, infectious
diseases, drug abuse, behavioral science,
health education, healthcare delivery,
state health programs, clinical care,
preventive health, medical education,
health services and clinical research,
healthcare financing and other related
disciplines will be considered. The
committee shall have at least four
members who shall be persons living
with HIV/AIDS.
Members may be invited to serve for
terms of up to four years. The HHS
policy stipulates that committee
membership be balanced in terms of
professional training and background,
points of view represented and the
committee’s function. Consideration is
given to a broad representation of
geographic areas within the U.S., with
equitable representation of the sexes,
PO 00000
Frm 00019
Fmt 4703
Sfmt 4703
ethnic and racial minorities, and
persons with disabilities. Nominees
must be U.S. citizens, and cannot be
full-time employees of the U.S.
Government.
Candidates should submit the
following items:
• Current curriculum vitae, including
complete contact information
(telephone numbers, mailing address,
email address)
• A letter of recommendation from
person(s) not employed by the U.S.
Department of Health and Human
Services
• A statement indicating the
nominee’s willingness to serve as a
potential member of the Committee.
Nominations should be submitted
electronically to zkr7@cdc.gov or in
writing, to: Margie Scott-Cseh,
Committee Management Specialist,
NCHHSTP, CDC, 1600 Clifton Road NE.,
Mailstop: E07, Atlanta, GA 30333. All
nominations must be postmarked by
April 30, 2014.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention, and the Agency for Toxic
Substances and Disease Registry.
Gary J. Johnson
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2014–00045 Filed 1–7–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Request for Nominations of
Candidates To Serve on the Advisory
Council for the Elimination of
Tuberculosis, Centers for Disease
Control and Prevention, Department of
Health and Human Services
The Centers for Disease Control and
Prevention (CDC) is soliciting
nominations for possible membership
on the Advisory Council for the
Elimination of Tuberculosis (ACET).
ACET provides advice and
recommendations to the Secretary,
Department of Health and Human
Services (HHS); the Assistant Secretary
of Health; and the Director, CDC,
regarding program policies, strategies,
objectives, and priorities; address the
development and application of new
E:\FR\FM\08JAN1.SGM
08JAN1
]]>Agencies
[Federal Register Volume 79, Number 5 (Wednesday, January 8, 2014)]
[Notices]
[Pages 1379-1380]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-00042]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Board on Radiation and Worker Health, National Institute
for Occupational Safety and Health
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), and pursuant to the requirements of 42
CFR 83.15(a), the Centers for Disease Control and Prevention (CDC),
announces the following meeting of the Advisory Board on Radiation and
Worker Health (ABRWH or Advisory Board), National Institute for
Occupational Safety and Health (NIOSH):
Time and Date: (All times are Central Standard Time) 9 a.m.-5:30
p.m., January 28, 2014.
Public Comment Time and Date: (All times are Central Standard
Time) 5:30 p.m.-6:30 p.m., January 28, 2014.
*Please note that the public comment period may end before the
time indicated, following the last call for comments. Members of the
public who wish to provide public comments should plan to attend the
public comment session at the start time listed.
Place: Crowne Plaza, 1301 Wyandotte, Kansas City, MO, 64105
Phone: 816-460-6664; Fax: 816-474-0424. Audio Conference Call via
FTS Conferencing. The USA toll-free, dial-in number is 1-866-659-
0537 with a pass code of 9933701. Live Meeting Connection: https://www.livemeeting.com/cc/cdc/join?id=JKQMG2&role=attend&pw=ABRWH;
Meeting ID: JKQMG2; Entry Code: ABRWH
Status: Open to the public, limited only by the space available.
The meeting space accommodates approximately 150 people.
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program Act of 2000 to
advise the President on a variety of policy and technical functions
required to implement and effectively manage the new compensation
program. Key functions of the Advisory Board include providing
advice on the development of probability of causation guidelines
which have been promulgated by the Department of Health and Human
Services (HHS) as a final rule, advice on methods of dose
reconstruction which have also been promulgated by HHS as a final
rule, advice on the scientific validity and quality of dose
estimation and reconstruction efforts being performed for purposes
of the compensation program, and advice on petitions to add classes
of workers to the Special Exposure Cohort (SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to the CDC. NIOSH implements
this responsibility for CDC. The charter was issued on August 3,
2001, renewed at appropriate intervals, and will expire on August 3,
2015.
Purpose: This Advisory Board is charged with a) providing advice
to the Secretary, HHS, on the development of guidelines under
Executive Order 13179; b) providing advice to the Secretary, HHS, on
the scientific validity and quality of dose reconstruction efforts
performed for this program; and c) upon request by the Secretary,
HHS, advise the Secretary on whether there is a class of employees
at any Department of Energy facility who were exposed to radiation
but for whom it is not feasible to estimate their radiation dose,
and on whether there is reasonable likelihood that such radiation
doses may have endangered the health of members of this class.
Matters To Be Discussed: The agenda for the Advisory Board
meeting includes: NIOSH Program Update; Department of Labor Program
Update; Department of Energy Program Update; SEC petitions for:
Joslyn Manufacturing and Supply Company (Fort Wayne, IN) and Kansas
City Plant (Kansas City, MO); SEC Issues Work Group Report on
``Sufficient Accuracy''/Co-Worker Dose Modeling; SEC Petitions
Update, and Board Work Sessions.
The agenda is subject to change as priorities dictate.
In the event an individual cannot attend, written comments may
be submitted in accordance with the redaction policy provided below.
Any written comments received will be provided at the meeting and
should be submitted to the contact person below well in advance of
the meeting.
Policy on Redaction of Board Meeting Transcripts (Public
Comment): (1) If a person making a comment gives his or her personal
information, no attempt will be made to redact the name; however,
NIOSH will redact other personally identifiable information, such as
contact information, social security numbers, case numbers, etc., of
the commenter.
(2) If an individual in making a statement reveals personal
information (e.g., medical or employment information) about
themselves that information will not usually be redacted. The NIOSH
Freedom of Information Act (FOIA) coordinator will, however, review
such revelations in accordance with the Federal Advisory Committee
Act and if deemed appropriate, will redact such information.
(3) If a commenter reveals personal information concerning a
living third party, that information will be reviewed by the NIOSH
FOIA coordinator, and upon determination, if deemed appropriate,
such information will be redacted, unless the disclosure is made by
the third party's authorized representative under the Energy
Employees Occupational Illness Compensation Program Act (EEOICPA)
program.
(4) In general, information concerning a deceased third party
may be disclosed; however, such information will be redacted if (a)
the disclosure is made by an individual other than the survivor
claimant, a parent, spouse, or child, or the authorized
representative of the deceased third party; (b)
[[Page 1380]]
if it is unclear whether the third party is living or deceased; or
(c) the information is unrelated or irrelevant to the purpose of the
disclosure.
The Board will take reasonable steps to ensure that individuals
making public comment are aware of the fact that their comments
(including their name, if provided) will appear in a transcript of
the meeting posted on a public Web site. Such reasonable steps
include: (a) A statement read at the start of each public comment
period stating that transcripts will be posted and names of speakers
will not be redacted; (b) A printed copy of the statement mentioned
in (a) above will be displayed on the table where individuals sign
up to make public comments; (c) A statement such as outlined in (a)
above will also appear with the agenda for a Board Meeting when it
is posted on the NIOSH Web site; (d) A statement such as in (a)
above will appear in the Federal Register Notice that announces
Board and Subcommittee meetings.
Contact Person For More Information: Theodore Katz, M.P.A.,
Designated Federal Officer, NIOSH, CDC, 1600 Clifton Road NE., MS E-
20, Atlanta, GA 30333, Telephone: (513) 533-6800, Toll Free: 1-800-
CDC-INFO, Email: dcas@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register Notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Gary J. Johnson,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2014-00042 Filed 1-7-14; 8:45 am]
BILLING CODE 4163-18-P
